Fresenius Medical Care AG annual ebitda
2017
2019
2020
2021
2022
2023
2024
2025
Fresenius Medical Care AG EBITDA Growth & History (FMS)
Fresenius Medical Care AG's calculated EBITDA was €3.29B for fiscal 2025.
View full Fresenius Medical Care AG company overviewFresenius Medical Care AG annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.29B | €362.5M | +12.38% |
| 2024 | 2024-12-31 | €2.93B | −€54.2M | −1.82% |
| 2023 | 2023-12-31 | €2.98B | −€248.4M | −7.69% |
| 2022 | 2022-12-31 | €3.23B | −€207.1M | −6.02% |
| 2021 | 2021-12-31 | €3.44B | −€453.6M | −11.66% |
| 2020 | 2020-12-31 | €3.89B | €68.3M | +1.79% |
| 2019 | 2019-12-31 | €3.82B | €725.0M | +23.40% |
| 2017 | 2017-12-31 | €3.10B | — | — |
Fresenius Medical Care AG quarterly ebitda
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | €954.4M | €303.6M | +46.65% |
| Q3 2025 | 2025-09-30 | €834.7M | −€70,000 | −0.01% |
| Q2 2025 | 2025-06-30 | €787.3M | −€21.2M | −2.63% |
| Q1 2025 | 2025-03-31 | €714.0M | €80.2M | +12.66% |
| Q4 2024 | 2024-12-31 | €650.8M | −€179.2M | −21.59% |
| Q3 2024 | 2024-09-30 | €834.8M | €117.9M | +16.45% |
| Q2 2024 | 2024-06-30 | €808.6M | €45.9M | +6.01% |
| Q1 2024 | 2024-03-31 | €633.7M | −€38.8M | −5.77% |
| Q4 2023 | 2023-12-31 | €830.1M | €38.2M | +4.82% |
| Q3 2023 | 2023-09-30 | €716.9M | −€197.4M | −21.59% |
| Q2 2023 | 2023-06-30 | €762.7M | €165,000 | +0.02% |
| Q1 2023 | 2023-03-31 | €672.5M | −€89.3M | −11.72% |
| Q4 2022 | 2022-12-31 | €791.9M | −€71.4M | −8.28% |
| Q3 2022 | 2022-09-30 | €914.3M | €13.2M | +1.47% |
| Q2 2022 | 2022-06-30 | €762.5M | −€48.6M | −5.99% |
| Q1 2022 | 2022-03-31 | €761.8M | −€100.3M | −11.64% |
| Q4 2021 | 2021-12-31 | €863.4M | €15.6M | +1.84% |
| Q3 2021 | 2021-09-30 | €901.1M | −€126.9M | −12.34% |
| Q2 2021 | 2021-06-30 | €811.1M | −€249.7M | −23.54% |
| Q1 2021 | 2021-03-31 | €862.2M | −€92.6M | −9.70% |
| Q4 2020 | 2020-12-31 | €847.7M | −€163.4M | −16.16% |
| Q3 2020 | 2020-09-30 | €1.03B | €23.3M | +2.32% |
| Q2 2020 | 2020-06-30 | €1.06B | €152.5M | +16.79% |
| Q1 2020 | 2020-03-31 | €954.8M | €55.9M | +6.22% |
| Q4 2019 | 2019-12-31 | €1.01B | €305.6M | +43.32% |
| Q3 2019 | 2019-09-30 | €1.00B | −€576.7M | −36.47% |
| Q2 2019 | 2019-06-30 | €908.3M | €236.4M | +35.18% |
| Q1 2019 | 2019-03-31 | €898.9M | €197.9M | +28.24% |
| Q3 2018 | 2018-09-30 | €705.5M | −€80.9M | −10.28% |
| Q2 2018 | 2018-06-30 | €1.58B | €812.0M | +105.54% |
| Q1 2018 | 2018-03-31 | €671.9M | −€169.3M | −20.13% |
| Q4 2017 | 2017-12-31 | €701.0M | — | — |
| Q3 2017 | 2017-09-30 | €786.4M | — | — |
| Q2 2017 | 2017-06-30 | €769.4M | — | — |
| Q1 2017 | 2017-03-31 | €841.2M | — | — |
Fresenius Medical Care AG ebitda trends
Over the last five reported fiscal years, Fresenius Medical Care AG's ebitda decreased from €3.89B to €3.29B, a change of −€600.8M. The latest reported quarter, Q4 2025, shows €954.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fresenius Medical Care AG filings at SEC.gov ↗